Search for: "K-V Pharmaceutical Company" Results 21 - 40 of 221
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Oct 2011, 6:10 am by Joe Palazzolo
A spokesman for K-V said that the company believes that Hermelin’s lawsuit is without merit. [read post]
24 Mar 2013, 9:56 pm by Lisa Larrimore Ouellette
Watson), in which the Court will decide when a brand-name pharmaceutical company may offer a "reverse payment" settlement to a generic company in exchange for the generic dropping a patent challenge and staying out of the market. [read post]
13 Aug 2012, 1:13 am by Kevin LaCroix
On August 1, 2012, Southern District of Florida Judge Marcia Cook, in the securities class action lawsuit involving Jiangbo Pharmaceuticals, granted the motions to dismiss of the company’s CFO, Elsa Sung, and of its auditor. [read post]
13 Aug 2012, 1:13 am by Kevin LaCroix
On August 1, 2012, Southern District of Florida Judge Marcia Cook, in the securities class action lawsuit involving Jiangbo Pharmaceuticals, granted the motions to dismiss of the company’s CFO, Elsa Sung, and of its auditor. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Granted Anoop K Joy 1251/KOL/2006 OTSUKA PHARMACEUTICAL CO. [read post]
22 Jun 2012, 3:22 pm by Steven G. Pearl
In light of this requirement, pharmaceutical companies have long focused their direct marketing efforts on physicians. [read post]
28 May 2019, 6:47 pm by Kevin LaCroix
The company then attached the patent application – including the interim results – to an SEC filing on Form 8-K. [read post]
20 May 2011, 11:15 pm by Apeng
Leave granted to appeal to Supreme Court of Canada on K-12 decision – CMEC v. [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]